frontotemporal dementia
Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia.
Suberoylanilide hydroxamic acid (vorinostat) up-regulates <span class="gene" id="21454553-0-58-69">progranulin</span> transcription: rational therapeutic approach to <span class="disease" id="21454553-0-118-141">frontotemporal dementia</span>.